 |
|
|
 |
|
Therapeutic Cloning Works in Mice With Parkinson's
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 | 3 "It had been thought that this process would be way too cumbersome to carry out," said Tabar. "But this validates that it is feasible and superior to using non-matched genetic material."
Michael Jakowec, an assistant professor of neurology with the George and MaryLou Boone Parkinson's Disease and Movement Disorders Research Center at the University of Southern California Keck School of Medicine in Los Angeles, cautioned that the leap to humans might be "gigantic."
"You see a lot of failures in studies that try to translate success from rodents to humans," Jakowec said. "So, it may be premature to take this to human trial just yet. Perhaps it should first be replicated in primates. But it certainly does open up a new avenue of therapeutic strategy, which may ultimately benefit patients down the road."
Text Continues Below

More information
For more on Parkinson's treatment options, visit the National Parkinson Foundation.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 3/24/2008
|
 |

SOURCES: Viviane Tabar, M.D., associate professor, neurosurgery, department of neurosurgery, Memorial Sloan-Kettering Cancer Center, New York City; Michael Jakowec, Ph.D., assistant professor, neurology, George and MaryLou Boone Parkinson's Disease and Movement Disorders Research Center, University of Southern California Keck School of Medicine, Los Angeles; March 23, 2008, Nature Medicine, online
|